Audrey N.
- Country
- France
- Department
- Dermatology
Research Overview
- Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized trial
- Efficacy and Safety of Lebrikizumab in Adults With Nummular Dermatitis Inadequately Controlled by Topical Corticosteroids: A Phase 3, Randomized, Placebo-Controlled Study
- Evaluation of Subcutaneous Methotrexate Efficacy and Safety Compared to Placebo in Adults with Moderate to Severe Atopic Dermatitis
Data & Insights
Has run more than one trial at 36 of 164 partner sites.
Specializations
Dermatology Expertise
This investigator specializes in treating moderate to severe atopic dermatitis, with particular emphasis on innovative therapeutic approaches for both adolescent and adult patients.
- Biologic Therapies
- Systemic Treatments
- Long-term Disease Management
The investigator focuses on evaluating novel treatment options for patients who require advanced therapeutic interventions beyond conventional treatments.
Treatment Optimization
Their research encompasses therapeutic optimization strategies, including the evaluation of various administration methods and dosing regimens for dermatological conditions.
- Subcutaneous Administration
- Dose Modification Protocols
- Treatment Maintenance Strategies
Their work includes investigating step-down approaches and long-term maintenance protocols for sustained disease control.
Immunology Focus
The investigator demonstrates expertise in immunological interventions, including both traditional immunomodulators and newer biological agents.
- Novel Biological Agents
- Immunomodulatory Treatments
- Preventive Vaccination Studies
Their research extends to preventive medicine through vaccine studies, particularly in infectious disease prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.